MarketsFN
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
Stocks

Sandisk (SNDK) Q4 2026: Revenue Soars 372% YoY — Strongly Positive: Slides 8.6% at Open — Post-Earnings Analysis

QuoteReporter

•5 min read
Sandisk (SNDK) Q4 2026: Revenue Soars 372% YoY — Strongly Positive: Slides 8.6% at Open — Post-Earnings Analysis
EARNINGS DAY PRICE ACTION — SNDK
Slid Down -8.64%Prev close $1,330.05 → Open $1,215.09 — then slid 1.81% intraday

In the fiscal fourth quarter of 2026, Sandisk Corporation reported a remarkable revenue of $8.97 billion, representing a staggering increase of $7.07 billion or 372% year-over-year compared to $1.90 billion in Q4 2025. This performance not only highlights the company's robust growth trajectory but also underscores its successful strategic pivot towards higher-value customers, particularly in the datacenter segment.

Analyst View

This quarter is undoubtedly a strong win for shareholders. The significant revenue growth, coupled with a GAAP net income of $6.90 billion (up $6.92 billion from a net loss of $23 million in Q4 2025), showcases Sandisk's ability to capitalize on market opportunities and improve its profitability. The diluted net income per share also surged to $43.97, a remarkable increase from $(0.16) in the same quarter last year. Such performance metrics indicate a solid operational turnaround and a promising outlook for the company.

Key Financial Metrics

  • Q4 2026 Revenue: $8.97 billion (up 372% YoY)
  • GAAP Net Income: $6.90 billion (up $6.92 billion YoY)
  • Diluted Net Income per Share: $43.97 (up from $(0.16) YoY)
  • Gross Margin: 84.6% (up 58.4 percentage points YoY)
  • Operating Income: $545 million (up 14% YoY)
  • Operating Expenses: $7.04 billion (up 71% YoY)

Shareholder Returns and Future Guidance

In a move that reflects confidence in its financial health, Sandisk's Board of Directors has approved an additional $14 billion share repurchase program, bringing the total remaining authorization to $15.5 billion. This buyback initiative is likely to enhance shareholder value and signal management's commitment to returning capital to investors.

Looking ahead, Sandisk expects first-quarter 2027 revenue to be in the range of $10.30 billion to $10.80 billion, with anticipated Non-GAAP diluted net income per share between $44.00 and $46.00. This guidance suggests continued momentum and growth potential as the company capitalizes on its strategic initiatives.

Forward Catalysts

Investors should closely monitor Sandisk's performance in the datacenter segment, which has shown explosive growth of 437% year-over-year, contributing significantly to overall revenue. Additionally, the company's ongoing efforts to expand its New Business Model agreements will be crucial in sustaining growth and enhancing customer relationships. The upcoming earnings call will provide further insights into these initiatives and the company's strategic direction.

In conclusion, Sandisk's Q4 2026 results reflect a transformative period for the company, characterized by exceptional revenue growth, improved profitability, and a strong commitment to shareholder returns. As the company continues to execute its strategic vision, it remains well-positioned for future success.

Note: All amounts in the following tables are in millions.

Quarterly Earnings — Revenue vs. Estimate

Quarter Label Quarter End Rev Actual ($M) Rev Est ($M) Rev Var ($M) EPS Actual EPS Est EPS Beat
Q1 2027 2026-10 11,030 — — 49.51 46.19 +3.32
Q4 2026 2026-06-30 8,970 — — 39.25 33.28 +5.97
Q3 2026 2026-03-31 5,950 — — 23.41 14.17 +9.24
Q2 2026 2025-12-31 3,030 2,670 +360 6.20 3.31 +2.89
Q1 2026 2025-09-30 2,310 2,120 +190 1.22 0.58 +0.64

Revenue vs. Estimate — 5 Quarters

Revenue vs Estimate

EPS vs. Estimate — 5 Quarters

EPS vs Estimate

Technical Analysis — 90-Day Price Chart

Technical Analysis Chart

SanDisk Corporation (SNDK) trades at $1193.24, significantly below its key moving averages—SMA20 ($1420.88), SMA50 ($1558.76), and SMA200 (not provided)—confirming a strong downtrend with no bullish crossovers in sight. The RSI(14) at 31.5 approaches oversold territory but lacks reversal confirmation, suggesting continued bearish momentum. Volume at 5,946,775 is 26% below the 20-day average of 8,082,048, indicating weak participation in the current downtrend. Positioned at the lower mid-range of its 52-week high ($2348.0) and low ($998.19), SNDK shows no immediate support beyond the psychological $1000 level, while resistance aligns with the SMA20. The stock's proximity to yearly lows reflects persistent selling pressure, requiring a sustained volume-backed rebound to alter the bearish bias.

Disclaimer: The content on MarketsFN.com is provided for educational and informational purposes only. It does not constitute financial advice, investment recommendations, or trading guidance. All investments carry risk and past performance does not guarantee future results. You are solely responsible for your investment decisions and should conduct independent research and consult a qualified financial advisor before acting.

Related Articles

Starbucks Corporation (SBUX) Q4 2026: Calm Open (+0.2%) — Post-Earnings Analysis
Trending
Stocks

Starbucks Corporation (SBUX) Q4 2026: Calm Open (+0.2%) — Post-Earnings Analysis

QuoteReporter
2 minOct 30, 2026
Gilead Sciences (GILD) Q3 2026: Revenue Growth Amid Mixed Earnings — Cautiously Optimistic: Gaps +2.6% at Open — Post-Earnings Analysis
Trending
Stocks

Gilead Sciences (GILD) Q3 2026: Revenue Growth Amid Mixed Earnings — Cautiously Optimistic: Gaps +2.6% at Open — Post-Earnings Analysis

QuoteReporter
5 minOct 30, 2026
Regeneron Pharmaceuticals (REGN) REGN Q3 Financial Results Summary
Trending
Stocks

Regeneron Pharmaceuticals (REGN) REGN Q3 Financial Results Summary

QuoteReporter
4 minOct 30, 2026